Small pharma company drug prevents cold sores in clinical trials
We have a drug that has significantly reduced cold sore outbreaks in 3 of 3 clinical trials to date. The market potential is $600 million per year in the U.S. alone. I can’t even get investment bankers or VCs to return my calls or e-mails. But we can raise the money through the real smart money, which is little guys. Go to https://wefunder.com/squarexllc to learn more and for the chance to invest.
via r/wallstreetbets https://ift.tt/3qhG8Zq
June 10, 2021 at 02:43PM